Co-operative study group for childhood acute lymphoblastic leukemia (COALL): Long-term follow-up of trials 82, 85, 89 and 92

Leukemia

Volumn 14, Issue 12, 2000, Pages 2234-2239

  Harms, D O ^a   Janka Schaub, G E ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Childhood; CNS control; Lymphoblastic leukemia; Outcome

Indexed keywords

ANTILEUKEMIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FEMALE; FOLLOW UP; GERMANY; HUMAN; INFANT; INFORMATION PROCESSING; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SKULL IRRADIATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034523201     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401974     Document Type: Article

References (13)

1. Acute lymphoblastic leukemia in childhood: The COALL therapy studies
2. Early intensification therapy in high-risk childhood acute lymphocytic leukemia: Lack of benefit from high-dose methotrexate
3. The COALL-85 cooperative study for risk patients with acute lymphatic leukemia: Initial results
4. Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood: Follow up after 9 years
5. In vitro drug resistance as independent prognostic factor in the study COALL-05-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria profiles in study COALL-06-97
6. Regression models and life-tables
7. Non-parametric estimation from incomplete observations
8. Initial response to therapy as an important prognostic factor in acute lymphoblastic leukemia in childhood
9. Prognostic significance of exposure to intermediate-dose methotrexate in children with standard risk ALL: The COALL 82/85 experience
10. Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine
11. Thioguanine offers no advantage over mercaptopurine in maintenance therapy (MT) of childhood ALL
12. Daunorubicin-induced cell kill with 1-hour vs. 24-hour infusions: Randomized comparison in newly diagnosed children with acute lymphoblastic leukemia
13. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)